Consultants

Dr. Nathan Jacobs is a Consultant in Infectious Diseases at Manchester University NHS Foundation Trust (MFT). His professional interests include emerging infectious diseases, tropical diseases, and pandemic preparedness. ResearchGate

Professional Background and Contributions:

• Research and Publications: Dr. Jacobs has co-authored several publications focusing on infectious diseases:

  • UK guidelines for the investigation and management of eosinophilia in returning travellers and migrants. Thakker C, Warrell C, Barrett J, Booth HL, Chiodini PL, Defres S, Falconer J, Jacobs N, Jones J, Lambert J, Leong C, McBride A, Moore E, Moshiri T, Nabarro LE, O’Hara G, Stone N, van Halsema C, Checkley AM; British Infection Association.J Infect. 2025 Feb;90(2):106328. doi: 10.1016/j.jinf.2024.106328.

  • Assessment and management of secondary bacterial infections complicating Mpox (Monkeypox) using a telemedicine service. A prospective cohort study. Moody S, Lamb T, Jackson E, Beech A, Malik N, Johnson L, Jacobs N. Int J STD AIDS. 2023 Jun;34(7):434-438. doi: 10.1177/09564624231162760.

  • Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study. Fink DL, Callaby H, Luintel A, Beynon W, Bond H, Lim EY, Gkrania-Klotsas E, Heskin J, Bracchi M, Rathish B, Milligan I, O’Hara G, Rimmer S, Peters JR, Payne L, Mody N, Hodgson B, Lewthwaite P, Lester R, Woolley SD, Sturdy A, Whittington A, Johnson L, Jacobs N, Quartey J, Ai Payne B, Crowe S, Elliott IA, Harrison T, Cole J, Beard K, Cusack TP, Jones I, Banerjee R, Rampling T; Specialist and High Consequence Infectious Diseases Centres Network for Monkeypox; Dunning J.Lancet Infect Dis. 2023 May;23(5):589-597. doi: 10.1016/S1473-3099(22)00806-4. Epub 2022 Dec 22.PMID: 36566771

Professional Affiliations:

• ResearchGate Profile: Dr. Jacobs maintains an active presence on ResearchGate, where he shares his research findings and collaborates with peers in the field of infectious diseases. ResearchGate

Public Engagement:

• Social Media: He engages with the public and healthcare community on platforms like X (formerly Twitter), discussing topics such as influenza trends and the importance of vaccinations. X.com

Dr. Jacobs’ dedication to research, clinical practice, and public health initiatives underscores his commitment to advancing the field of infectious diseases.

GMC: 7283762